VISTAGEN THERAPEUTICS, INC. Stock-Based Compensation
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Stock-Based Compensation of $991.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- VISTAGEN THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $991.00K, a 8.19% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $889.00K, a 7.68% decline year-over-year.
- VISTAGEN THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.10M, a 1.48% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.10M, a 1.44% decline year-over-year.
- VISTAGEN THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2026 was $4.00M, a 7.37% decline from fiscal 2025.
- VISTAGEN THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $4.32M, a 97.75% increase from fiscal 2024.
- VISTAGEN THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $2.18M, a 34.59% decline from fiscal 2023.
- VISTAGEN THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $3.34M, a 4.16% decline from fiscal 2022.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed | Share-based Payment Arrangement, Noncash Expense 157 month | Share-based Payment Arrangement, Noncash Expense 160 month | Share-based Payment Arrangement, Noncash Expense 163 month | Share-based Payment Arrangement, Noncash Expense 166 month | Share-based Payment Arrangement, Noncash Expense 169 month | Share-based Payment Arrangement, Noncash Expense 172 month | Share-based Payment Arrangement, Noncash Expense 175 month | Share-based Payment Arrangement, Noncash Expense 178 month | Share-based Payment Arrangement, Noncash Expense 181 month | Share-based Payment Arrangement, Noncash Expense 184 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $991.00K 10-Q · filed 2026-08-14 | $1.88M derived: sum of 2 quarters · filed 2026-08-14 | $2.98M derived: sum of 3 quarters · filed 2026-08-14 | $4.07M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||
| 2026-03-31 | $889.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15 | $1.99M derived: sum of 2 quarters · filed 2026-06-15 | $3.08M derived: sum of 3 quarters · filed 2026-06-15 | $4.00M 10-K · filed 2026-06-15 | ||||||||||||||
| 2025-12-31 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | $2.19M derived: sum of 2 quarters · filed 2026-02-12 | $3.11M 10-Q · filed 2026-02-12 | $4.07M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||
| 2025-09-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13 | $2.01M 10-Q · filed 2025-11-13 | $2.98M derived: sum of 3 quarters · filed 2026-08-14 | $4.05M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||
| 2025-06-30 | $916.00K 10-Q · filed 2026-08-14 | $1.88M derived: sum of 2 quarters · filed 2026-08-14 | $2.96M derived: sum of 3 quarters · filed 2026-08-14 | $4.07M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||||
| 2025-03-31 | $963.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15 | $2.04M derived: sum of 2 quarters · filed 2026-06-15 | $3.15M derived: sum of 3 quarters · filed 2026-06-15 | $4.32M 10-K · filed 2026-06-15 | ||||||||||||||
| 2024-12-31 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | $2.19M derived: sum of 2 quarters · filed 2026-02-12 | $3.35M 10-Q · filed 2026-02-12 | $3.87M derived: sum of 4 quarters · filed 2026-02-12 | ||||||||||||||
| 2024-09-30 | $1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13 | $2.27M 10-Q · filed 2025-11-13 | $2.79M derived: sum of 3 quarters · filed 2025-11-13 | $3.30M derived: sum of 4 quarters · filed 2025-11-13 | ||||||||||||||
| 2024-06-30 | $1.16M 10-Q · filed 2025-08-07 | $1.68M derived: sum of 2 quarters · filed 2025-08-07 | $2.19M derived: sum of 3 quarters · filed 2025-08-07 | $2.77M derived: sum of 4 quarters · filed 2025-08-07 | ||||||||||||||
| 2024-03-31 | $522.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-17 | $1.03M derived: sum of 2 quarters · filed 2025-06-17 | $1.61M derived: sum of 3 quarters · filed 2025-06-17 | $2.18M 10-K · filed 2025-06-17 | ||||||||||||||
| 2023-12-31 | $507.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | $1.09M derived: sum of 2 quarters · filed 2025-02-13 | $1.66M 10-Q · filed 2025-02-13 | $1.66M 10-Q · filed 2024-02-13 | $2.26M derived: sum of 4 quarters · filed 2025-02-13 | |||||||||||||
| 2023-09-30 | $584.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $1.15M 10-Q · filed 2024-11-07 | $1.15M 10-Q · filed 2023-11-09 | $1.75M derived: sum of 3 quarters · filed 2024-11-07 | $2.50M derived: sum of 4 quarters · filed 2024-11-07 | |||||||||||||
| 2023-06-30 | $569.00K 10-Q · filed 2024-08-13 | $569.10K 10-Q · filed 2023-08-10 | $1.17M derived: sum of 2 quarters · filed 2024-08-13 | $1.92M derived: sum of 3 quarters · filed 2024-08-13 | $2.95M derived: sum of 4 quarters · filed 2024-08-13 | |||||||||||||
| 2023-03-31 | $601.10K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-11 | $1.35M derived: sum of 2 quarters · filed 2024-06-11 | $2.38M derived: sum of 3 quarters · filed 2024-06-11 | $3.34M 10-K · filed 2024-06-11 | $3.34M 10-K · filed 2023-06-28 | |||||||||||||
| 2022-12-31 | $746.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-13 | $1.78M derived: sum of 2 quarters · filed 2024-02-13 | $2.73M 10-Q · filed 2024-02-13 | $4.14M derived: sum of 4 quarters · filed 2024-02-13 | ||||||||||||||
| 2022-09-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-09 | $1.99M 10-Q · filed 2023-11-09 | $3.39M derived: sum of 3 quarters · filed 2023-11-09 | $4.11M derived: sum of 4 quarters · filed 2023-11-09 | ||||||||||||||
| 2022-06-30 | $956.90K 10-Q · filed 2023-08-10 | $2.36M derived: sum of 2 quarters · filed 2023-08-10 | $3.08M derived: sum of 3 quarters · filed 2023-08-10 | $3.85M derived: sum of 4 quarters · filed 2023-08-10 | ||||||||||||||
| 2022-03-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-28 | $2.13M derived: sum of 2 quarters · filed 2023-06-28 | $2.89M derived: sum of 3 quarters · filed 2023-06-28 | $3.48M 10-K · filed 2023-06-28 | ||||||||||||||
| 2021-12-31 | $723.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-07 | $1.49M derived: sum of 2 quarters · filed 2023-02-07 | $2.08M 10-Q · filed 2023-02-07 | $2.57M derived: sum of 4 quarters · filed 2023-02-07 | ||||||||||||||
| 2021-09-30 | $764.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-10 | $1.35M 10-Q · filed 2022-11-10 | $1.35M 10-Q · filed 2021-11-10 | $2.58M derived: sum of 4 quarters · filed 2022-11-10 | ||||||||||||||
| 2021-06-30 | $590.40K 10-Q · filed 2022-08-11 | $1.08M derived: sum of 2 quarters · filed 2022-08-11 | $1.81M derived: sum of 3 quarters · filed 2022-08-11 | $2.22M derived: sum of 4 quarters · filed 2022-08-11 | ||||||||||||||
| 2021-03-31 | $490.20K derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-23 | $1.22M derived: sum of 2 quarters · filed 2022-06-23 | $1.63M derived: sum of 3 quarters · filed 2022-06-23 | $2.31M 10-K · filed 2022-06-23 | ||||||||||||||
| 2020-12-31 | $730.40K 10-Q · filed 2021-02-11 | $1.14M derived: sum of 2 quarters · filed 2021-02-11 | $1.82M 10-Q · filed 2022-02-10 | |||||||||||||||
| 2020-09-30 | $410.90K 10-Q · filed 2020-11-12 | $1.09M 10-Q · filed 2020-11-12 | $1.09M 10-Q · filed 2021-11-10 | |||||||||||||||
| 2020-06-30 | $674.60K 10-Q · filed 2021-08-12 | |||||||||||||||||
| 2019-12-31 | $1.63M 10-Q · filed 2021-02-11 | $2.03M derived: sum of 2 quarters · filed 2021-02-11 | $3.09M 10-Q · filed 2021-02-11 | |||||||||||||||
| 2019-09-30 | $393.50K 10-Q · filed 2020-11-12 | $1.46M 10-Q · filed 2020-11-12 | ||||||||||||||||
| 2019-06-30 | $1.06M 10-Q · filed 2020-08-13 | |||||||||||||||||
| 2018-12-31 | $734.70K 10-Q · filed 2020-02-13 | $1.91M derived: sum of 2 quarters · filed 2020-02-13 | $2.52M 10-Q · filed 2020-02-13 | |||||||||||||||
| 2018-09-30 | $1.17M 10-Q · filed 2019-11-07 | $1.78M 10-Q · filed 2019-11-07 | ||||||||||||||||
| 2018-06-30 | $612.60K 10-Q · filed 2019-08-13 | |||||||||||||||||
| 2017-12-31 | $689.30K 10-Q · filed 2019-02-12 | $1.02M derived: sum of 2 quarters · filed 2019-02-12 | $1.39M 10-Q · filed 2019-02-12 | |||||||||||||||
| 2017-09-30 | $330.60K 10-Q · filed 2018-10-29 | $697.60K 10-Q · filed 2018-10-29 | ||||||||||||||||
| 2017-06-30 | $367.00K 10-Q · filed 2018-08-14 | |||||||||||||||||
| 2016-12-31 | $267.20K 10-Q · filed 2018-02-12 | $466.00K derived: sum of 2 quarters · filed 2018-02-12 | $573.90K 10-Q · filed 2018-02-12 | |||||||||||||||
| 2016-09-30 | $198.80K 10-Q · filed 2017-11-09 | $306.70K 10-Q · filed 2017-11-09 | ||||||||||||||||
| 2016-06-30 | $107.90K 10-Q · filed 2017-08-14 | |||||||||||||||||
| 2015-12-31 | $98.40K 10-Q · filed 2017-02-13 | $3.84M derived: sum of 2 quarters · filed 2017-02-13 | $3.87M 10-Q · filed 2017-02-13 | $5.76M derived: sum of 4 quarters · filed 2017-02-13 | ||||||||||||||
| 2015-09-30 | $3.74M 10-Q · filed 2015-11-16 | $3.77M 10-Q · filed 2016-11-14 | $5.67M derived: sum of 3 quarters · filed 2016-08-12 | $5.82M derived: sum of 4 quarters · filed 2016-08-12 | ||||||||||||||
| 2015-06-30 | $29.20K 10-Q · filed 2016-08-12 | $1.93M derived: sum of 2 quarters · filed 2016-08-12 | $2.08M derived: sum of 3 quarters · filed 2016-08-12 | $2.29M derived: sum of 4 quarters · filed 2016-08-12 | ||||||||||||||
| 2015-03-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-29 | $2.05M derived: sum of 2 quarters · filed 2016-02-16 | $2.26M derived: sum of 3 quarters · filed 2016-02-16 | $2.46M 10-K · filed 2015-06-29 | ||||||||||||||
| 2014-12-31 | $155.60K 10-Q · filed 2016-02-16 | $155.50K 10-Q · filed 2015-02-17 | $360.60K derived: sum of 2 quarters · filed 2016-02-16 | $564.00K 10-Q · filed 2016-02-16 | $807.60K derived: sum of 4 quarters · filed 2016-02-16 | |||||||||||||
| 2014-09-30 | $205.00K 10-Q · filed 2015-11-16 | $408.40K 10-Q · filed 2015-11-16 | $652.00K derived: sum of 3 quarters · filed 2015-11-16 | $1.12M derived: sum of 4 quarters · filed 2015-11-16 | ||||||||||||||
| 2014-06-30 | $203.40K 10-Q · filed 2015-08-14 | $447.00K derived: sum of 2 quarters · filed 2015-08-14 | $916.40K derived: sum of 3 quarters · filed 2015-08-14 | $1.14M derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||||
| 2014-03-31 | $243.60K derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-29 | $713.00K derived: sum of 2 quarters · filed 2015-06-29 | $939.20K derived: sum of 3 quarters · filed 2015-06-29 | $1.14M 10-K · filed 2015-06-29 | $6.73M 10-K · filed 2014-06-25 | |||||||||||||
| 2013-12-31 | $469.40K 10-Q · filed 2015-02-17 | $469.30K 10-Q · filed 2014-02-14 | $695.60K derived: sum of 2 quarters · filed 2015-02-17 | $893.70K 10-Q · filed 2015-02-17 | $1.17M derived: sum of 4 quarters · filed 2015-02-17 | $6.49M 10-Q · filed 2014-02-14 | ||||||||||||
| 2013-09-30 | $226.20K 10-Q · filed 2014-11-19 | $424.30K 10-Q · filed 2014-11-19 | $703.60K derived: sum of 3 quarters · filed 2014-11-19 | $1.52M derived: sum of 4 quarters · filed 2014-11-19 | $6.02M 10-Q · filed 2013-11-14 | |||||||||||||
| 2013-06-30 | $198.10K 10-Q · filed 2014-08-12 | $477.40K derived: sum of 2 quarters · filed 2014-08-12 | $1.29M derived: sum of 3 quarters · filed 2014-08-12 | $1.37M derived: sum of 4 quarters · filed 2014-08-12 | $5.79M 10-Q · filed 2013-08-14 | |||||||||||||
| 2013-03-31 | $279.30K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-25 | $1.09M derived: sum of 2 quarters · filed 2014-06-25 | $1.17M derived: sum of 3 quarters · filed 2014-06-25 | $1.24M 10-K · filed 2014-06-25 | $5.60M 10-K · filed 2013-07-18 | |||||||||||||
| 2012-12-31 | $813.70K 10-Q · filed 2014-02-14 | $891.00K derived: sum of 2 quarters · filed 2014-02-14 | $962.00K 10-Q · filed 2014-02-14 | $1.11M derived: sum of 4 quarters · filed 2014-02-14 | $5.32M 10-Q · filed 2013-02-14 | |||||||||||||
| 2012-09-30 | $77.30K 10-Q · filed 2012-11-14 | $148.30K 10-Q · filed 2013-11-14 | $292.20K derived: sum of 3 quarters · filed 2013-08-14 | $760.30K derived: sum of 4 quarters · filed 2013-08-14 | $4.50M 10-Q · filed 2012-11-14 | |||||||||||||
| 2012-06-30 | $71.00K 10-Q · filed 2013-08-14 | $214.90K derived: sum of 2 quarters · filed 2013-08-14 | $683.00K derived: sum of 3 quarters · filed 2013-08-14 | $1.22M derived: sum of 4 quarters · filed 2013-08-14 | $4.43M 10-Q · filed 2012-08-14 | |||||||||||||
| 2012-03-31 | $143.90K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-18 | $612.00K derived: sum of 2 quarters · filed 2013-07-18 | $1.15M derived: sum of 3 quarters · filed 2013-07-18 | $1.59M 10-K · filed 2013-07-18 | $4.35M 10-K · filed 2012-07-02 | |||||||||||||
| 2011-12-31 | $468.10K 10-Q · filed 2013-02-14 | $1.01M derived: sum of 2 quarters · filed 2013-02-14 | $1.45M 10-Q · filed 2013-02-14 | $1.45M 10-Q · filed 2012-02-14 | $1.85M derived: sum of 4 quarters · filed 2013-02-14 | $4.21M 10-Q · filed 2012-02-14 | ||||||||||||
| 2011-09-30 | $539.60K 10-Q · filed 2012-11-14 | $979.40K 10-Q · filed 2012-11-14 | $979.36K 10-Q · filed 2011-11-14 | $1.39M derived: sum of 3 quarters · filed 2012-11-14 | $1.79M derived: sum of 4 quarters · filed 2012-11-14 | $3.74M 10-Q · filed 2011-11-14 | ||||||||||||
| 2011-06-30 | $439.70K 10-Q · filed 2012-08-14 | $439.74K 10-Q · filed 2011-08-22 | $846.58K derived: sum of 2 quarters · filed 2012-08-14 | $1.25M derived: sum of 3 quarters · filed 2012-08-14 | $1.66M derived: sum of 4 quarters · filed 2012-08-14 | $3.20M 10-Q · filed 2011-08-22 | ||||||||||||
| 2011-03-31 | $406.88K derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-02 | $813.80K derived: sum of 2 quarters · filed 2012-07-02 | $1.22M derived: sum of 3 quarters · filed 2012-07-02 | $1.63M 10-K · filed 2012-07-02 | ||||||||||||||
| 2010-12-31 | $406.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-14 | $813.84K derived: sum of 2 quarters · filed 2012-02-14 | $1.22M 10-Q · filed 2012-02-14 | |||||||||||||||
| 2010-09-30 | $406.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-14 | $815.00K 10-Q · filed 2011-11-14 | ||||||||||||||||
| 2010-06-30 | $408.07K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |